aleapVENTURES

Personal invitation

Aleap Ventures
Investor Meeting

An update on our fund, portfolio progress and the opportunities ahead – followed by networking with the Aleap team and fellow investors.

Tuesday October 28th, 2026

17:00 – 21:00

Aleap

Gaustadalléen 21
Oslo, Norway

We look forward to seeing you!

Portfolio

Aleap Venture Portfolio

  • TRx Therapeutics

    Next-generation cell therapy, with programs entering Phase I clinical trials in leukemia.

  • Respinor

    Bringing the first continuous, non-invasive respiratory monitor to critical care, CE-marked and heading for the US.

  • Thelper

    First-in-class immunotherapy targeting a viral marker abundant in aggressive tumors.

  • Klyv Therapeutics

    First-in-class therapy targeting cardiac fibrosis to transform the treatment of heart failure.

  • RAB Diagnostics

    Unlocking precision immunotherapy by predicting which patients will respond to immunotherapy.

  • Alarmin Therapeutics

    First-in-class approach to treatment of patients with chronic lung disease.

Registration

Register as an investor

Let us know you are coming. Your registration is sent directly to the Aleap team.